Company profile: Advicenne
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical treatments targeting rare kidney diseases, developing and commercializing therapies in nephrology. Portfolio includes Sibnayal for distal renal tubular acidosis (dRTA); licensed medications Likozam (clobazam) and Levidcen (levetiracetam) in France; and ADV7103, an experimental late-stage therapy for dRTA and cystinuria in children and adults.
Products and services
- ADV7103: A late-stage drug candidate developed to treat distal Renal Tubular Acidosis and cystinuria in children and adults
- Sibnayal: An approved medication combining Potassium citrate and Potassium bicarbonate, engineered to treat rare renal diseases such as distal Renal Tubular Acidosis (dRTA)
- Levidcen: A licensed medication under Desitin GmbH, currently marketed in France, supplying Levetiracetam for conditions requiring Levetiracetam
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Advicenne
Expedeon
HQ: United States
Website
- Description: Provider of cutting-edge innovative reagents and services for life sciences and diagnostics, with applications across workflows including protein electrophoresis, liquid biopsy, whole genome amplification, antibody- and protein-labeling, and immunoassay development; offering off-the-shelf products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Expedeon company profile →
Intelligent BioSystems
HQ: United States
Website
- Description: Provider of an advanced DNA sequencing system, focused on commercialization. Founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju, the company builds on Dr. Gordon’s prior role founding Intelligent Automation Systems, which delivered key instrumentation solutions that helped complete the Human Genome Project.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent BioSystems company profile →
ImmunoVision
HQ: United States
Website
- Description: Provider of proprietary diagnostic reagents and test kits, specializing in their manufacture and marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunoVision company profile →
Agilent
HQ: United States
Website
- Description: Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agilent company profile →
PanThera CryoSolutions
HQ: Canada
Website
- Description: Provider of cryopreservation solutions for cells, tissues, and organs, featuring IRIs that control ice crystal size and growth to improve cell recovery/quality and reduce warming damage; IRIs mitigate toxicity of conventional cryoprotective agents to enable higher sub-zero storage temperatures, with GMP-compliant manufacturing and less costly storage/transport, restricting liquid nitrogen use in some cell treatment applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PanThera CryoSolutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Advicenne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Advicenne
2.2 - Growth funds investing in similar companies to Advicenne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Advicenne
4.2 - Public trading comparable groups for Advicenne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →